ZTS
Zoetis Inc.
NYSE · USHealthcareDrug Manufacturers - Specialty & Generic
$76.19-0.48%
Price as of Jul 20, 2026
ZTS profitability
Zoetis Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 70.8%
- EBITDA margin
- 42.4%
- EBIT margin
- 37.6%
- Net margin
- 27.8%
- Free cash flow margin
- 22.5%
Returns
- Return on equity
- 81.8%
- Return on assets
- 17.4%
- Return on invested capital
- 28.7%
- Asset turnover
- 0.62x
Cash efficiency
- Cash from operations
- $2.7B
- Cash per share
- $4.63
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.